PREDICTING MINS WITH FRAILTY AND BIOMARKERS IN GERIATRIC SURGERY
2026年4月30日 更新者:DİLEK KALAYCI
THE ROLE OF FRAILTY INDICES AND PREOPERATIVE BIOMARKERS IN PREDICTING MYOCARDIAL INJURY AFTER NON-CARDIAC SURGERY IN ELDERLY ORTHOPEDIC PATIENTS: A MACHINE LEARNING ANALYSIS
The primary objective of this study is to develop and validate a machine learning model that integrates preoperative clinical data, biomarkers, and modified frailty indices (mFI-5) to accurately predict myocardial injury after non-cardiac surgery (MINS) in geriatric patients ($\ge$65 years) undergoing major orthopedic surgery and requiring postoperative intensive care.
The research aims to compare the predictive performance of advanced algorithms, such as XGBoost and Random Forest, against traditional clinical risk scores like the Revised Cardiac Risk Index (RCRI), while specifically evaluating the impact of frailty on the model's area under the curve (AUC).
Furthermore, by identifying the most critical preoperative predictors, this study seeks to establish an objective clinical decision support mechanism to guide clinicians in the early risk stratification of high-risk geriatric patients.
研究概览
地位
主动,不招人
详细说明
Myocardial injury after non-cardiac surgery (MINS) is defined as a troponin elevation occurring within the first 30 days following a surgical intervention, presumed to be caused by myocardial ischemia.
Unlike the traditional diagnosis of myocardial infarction, MINS follows a "silent" course in more than 90% of cases, without ischemic symptoms or ECG changes.
However, this silent progression is misleading; the 30-day postoperative mortality risk for patients who develop MINS is approximately 10 times higher than for those who do not.
The geriatric orthopedic population, in particular, is in the highest risk group for this complication due to comorbidities and reduced physiological reserve.
Currently, tools used in perioperative risk assessment, such as the Revised Cardiac Risk Index (RCRI) or ACS-NSQIP, focus primarily on chronic organ failures and remain insufficient in reflecting the dynamic physiological state of the geriatric patient.
The low predictive success (AUC 0.54-0.62) of these scoring systems in the geriatric surgical group proves that clinicians require more precise tools for risk management.The Revised Cardiac Risk Index (RCRI), also known in the literature as the 'Lee Index,' is a widely used scoring system to predict perioperative major adverse cardiac events based on six clinical variables: high-risk surgery type, history of ischemic heart disease, congestive heart failure, history of cerebrovascular disease, preoperative insulin use, and a serum creatinine level above 2 mg/dL.
However, RCRI focuses largely on the patient's existing chronic diagnoses; it does not account for the biological reserve loss that develops with aging, the depth of anemia, and specifically, the acute inflammatory response and fluid-electrolyte shifts triggered by orthopedic surgery.
This situation significantly limits the sensitivity of RCRI in detecting silent myocardial injury (MINS) in the geriatric population.
Given the high surgical urgency and stress in geriatric orthopedic patients, the early prediction of cardiovascular events has become a vital necessity.A review of the existing literature reveals that MINS prediction has focused either solely on clinical risk scores or on individual biomarkers (hs-cTnT, NT-proBNP).
However, the concept of frailty, although it indicates the patient's biological reserve independent of chronological age, has not been sufficiently integrated into perioperative risk models.
The combined effect of the "objective biological stress" data provided by biomarkers and the "physiological resilience" data provided by frailty indices has not yet been comprehensively modeled, specifically for orthopedic geriatrics.
Traditional statistical methods struggle to capture the complex and non-linear relationships between these multidimensional data.
There is a lack of a preoperative model in the literature where these variables are synthesized with machine learning algorithms.The primary objective of this study is to develop and validate a machine learning model that accurately predicts myocardial injury (MINS) following surgery in geriatric patients ($\ge$65 years) undergoing major orthopedic surgery and followed in the postoperative intensive care unit, by integrating only preoperative clinical data, biomarkers, and modified frailty indices.
In addition to the primary aim of the research, the study intends to: compare the predictive performance of advanced machine learning models (XGBoost, Random Forest) with traditional clinical risk scores (Revised Cardiac Risk Index) used widely in the literature; reveal the impact of adding validated frailty indices (mFI-5) to patients' existing comorbidities on the model's predictive power (AUC); rank the preoperative variables with the highest predictive value in determining MINS risk in geriatric orthopedic patients; and provide a risk classification based on objective data to guide clinicians in the preoperative identification of high-risk patients.
研究类型
观察性的
注册 (估计的)
600
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Ankara
-
Ankara、Ankara、土耳其(türkiye)、06630
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 年长者
接受健康志愿者
不
取样方法
非概率样本
研究人群
The study population consists of geriatric patients (aged 65 years) undergoing major orthopedic surgery and requiring postoperative intensive care unit follow-up.
Eligible participants must have at least one cardiac troponin level measured within the first 72 hours postoperatively.
Patients on chronic dialysis due to end-stage renal disease and those with insufficient preoperative laboratory data will be excluded.
The population is selected to represent high-risk geriatric patients in a tertiary training and research hospital setting
描述
Inclusion Criteria:
- All patients aged 65 years and older.
- Patients undergoing major orthopedic surgery (hip fracture repair, total knee/hip arthroplasty, and revision surgeries).
- Patients operated on within the designated study period (January 2021 - December 2023).
- Patients with complete access to preoperative clinical data (comorbidities, medication use) and baseline laboratory parameters (Hemoglobin, Creatinine, Albumin).
- Patients who had at least one postoperative cardiac troponin (hs-cTn) measurement within the first 72 hours after surgery.
Exclusion Criteria:
- Patients with a documented history of acute myocardial infarction or elevated baseline troponin levels in the preoperative period (to differentiate acute injury from surgical causes).
- Patients with end-stage renal disease (ESRD) requiring dialysis (as chronic kidney dysfunction persistently elevates baseline troponin levels).
- Patients with missing critical preoperative data or incomplete postoperative troponin follow-up.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Geriatric Orthopedic Surgery Patients
Geriatric patients aged 65 years and older who undergo major orthopedic surgery and are followed in the postoperative intensive care unit.
This cohort includes patients evaluated for myocardial injury after non-cardiac surgery (MINS) using preoperative clinical data, biomarkers, and frailty indices.
|
Standard clinical care for major orthopedic surgery including preoperative assessment of biomarkers (hs-cTnT, NT-proBNP), frailty screening (mFI-5), and clinical data collection for the development of a machine learning-based MINS prediction model.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Incidence of Myocardial Injury after Non-cardiac Surgery (MINS)
大体时间:30 days postoperatively
|
The area under the receiver operating characteristic curve (AUC-ROC) ,Percentage of participants) |
30 days postoperatively
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Comparison of Machine Learning Models vs. Traditional Risk Scores (RCRI).
大体时间:Up to 30 days post-surgery
|
AUC-ROC (Area Under the Curve) values.
|
Up to 30 days post-surgery
|
|
Identification and ranking of the most significant preoperative predictors for MINS.
大体时间:Through study completion, an average of 6 months
|
SHAP values or Feature Importance scores.
|
Through study completion, an average of 6 months
|
|
Identification and ranking of the most significant preoperative predictors for MINS
大体时间:Through study completion, an average of 1 year
|
SHAP values or Feature Importance scores.
|
Through study completion, an average of 1 year
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Dilek Kalaycı、Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年4月1日
初级完成 (估计的)
2026年6月1日
研究完成 (估计的)
2026年6月5日
研究注册日期
首次提交
2026年4月23日
首先提交符合 QC 标准的
2026年4月30日
首次发布 (实际的)
2026年5月4日
研究记录更新
最后更新发布 (实际的)
2026年5月4日
上次提交的符合 QC 标准的更新
2026年4月30日
最后验证
2026年4月1日
更多信息
与本研究相关的术语
其他研究编号
- 2026-04/85
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
IPD 计划说明
Individual participant data will not be shared to ensure patient confidentiality and to comply with institutional data protection policies.
However, study results and the final analysis will be made available through peer-reviewed publication
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.